Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rmed.2023.107327 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
From Screening to Therapy: A Personalized Approach to ROP in a National NICU Setting.
J Pers Med
August 2025
Ophthalmology Department Makarios Hospital, Nicosia 2011, Cyprus.
: We aimed to investigate the incidence, treatment patterns, and associated risk factors of type 1 retinopathy of prematurity (ROP) in the only tertiary-level Neonatal Intensive Care Unit (NICU) in Cyprus. : This retrospective study included all infants screened for ROP between January and December 2023. Data were collected from standardized NICU discharge summaries and included gestational age (GA), birth weight (BW), multiple birth, systemic infection, blood transfusion, oxygen therapy, surgical interventions, and ROP outcomes.
View Article and Find Full Text PDFFactors Influencing the Efficacy and Safety of Monoclonal Antibody Biologics in Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.
Lung
March 2025
Department of Pulmonary and Critical Care Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Background: Monoclonal antibody therapies targeting specific inflammatory pathways have shown potential in treating chronic obstructive pulmonary disease (COPD). However, the efficacy and safety of these treatments across different patient phenotypes remain uncertain.
Methods: This meta-analysis included 15 registered randomized controlled trials (RCTs) evaluating monoclonal antibodies targeting type 2 and non-type 2 inflammatory pathways in COPD.
The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review.
Front Immunol
April 2025
Department of Respiratory Medicine, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, Ningxia, China.
Asthma is a complex, chronic inflammatory condition of the airways that comes in many forms. Because different inflammatory processes drive it, we can generally categorize asthma into two main types: type 2 inflammatory asthma and non-type 2 inflammatory asthma. Type 2 inflammation is usually the culprit in most folks grappling with severe asthma.
View Article and Find Full Text PDFAn examination of type and non-type material deposited in various European scientific collections concludes that the sexual generation of Andricus truncicolus (Giraud, 1859), recently discovered through laboratory experiments and herein confirmed by molecular data, is synonymous with Andricus multiplicatus Giraud, 1859; the latter name becomes a junior synonym. We demonstrate that previously published phylogenetic analyses did not group these two taxa together due to morphological misidentification of the sexual form. We show that the mistakenly identified taxon is a species new to science, described herein as Andricus pseudomultiplicatus sp.
View Article and Find Full Text PDFSkin Surface Lipid-RNA Profile Obtained from Patients with Severe Asthma After Benralizumab Treatment.
J Asthma Allergy
November 2024
Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
Background: Examining human coding and non-coding RNAs present in skin surface lipids (SSL-RNAs) offers a promising approach to understanding the physiological state of the skin. Benralizumab treatment can reduce exacerbations and improve symptom control and quality of life in patients with severe eosinophilic asthma. Although this treatment effectively depletes peripheral blood eosinophils, the impact of benralizumab on SSL-RNA remains completely unknown.
View Article and Find Full Text PDF